PDCD2L Rabbit Polyclonal Antibody

SKU: orb381942

Description

The PDCD2L Antibody is suitable for IHC, WB. It is a Polyclonal, Unconjugated antibody which raised against Recombinant fusion protein of human PDCD2L .Purification: The antibody was purified by immunogen affinity chromatography.

Research Area

Epigenetics

Images & Validation

• Tested Applications: IHC, WB
• Dilution Range: WB: 1:500-2000, IHC-P: 1:50-200
• Reactivity: Human, Mouse, Rat

Key Properties

• Antibody Type: Primary Antibody
• Host: Rabbit
• Clonality: Polyclonal
• Immunogen: Recombinant fusion protein of human PDCD2L
• Target: PDCD2L
• Purification: The antibody was purified by immunogen affinity chromatography.
• Conjugation: Unconjugated

Storage & Handling

• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Form/Appearance: Liquid
• Buffer/Preservatives: 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Programmed cell death protein 2-like

Western blot analysis of PDCD2L expression in MCF7 (A), SKOV3 (B), mouse brain (C), mouse heart (D) whole cell lysates. (Predicted band size: 39 kD; Observed band size: 45 kD)

Immunohistochemical analysis of PDCD2L staining in human lung formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

Quick Database Links

Gene Symbol

PDCD2L

UniProt

Q9BRP1

NCBI Gene ID

84306

Ding-Ping Sun 1 2, Chun-Chao Chang 3 4 5, Hsuan-Yi Huang 1, Nai-Weng Kang 6, You-Cheng Hseu 7, Yu-Feng Tian 1, Chia-Lang Fang 5 8 9, Kai-Yuan Lin 10 PDCD2L overexpression represents an unfavorable prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer Cancer Biomark, (2025)

PubMed: 40891712